Preclinical evaluation of methanolic extract of Malus domestica peel on epilepsy in Swiss Albino mice using maximal electroshock test
DOI:
https://doi.org/10.18203/2319-2003.ijbcp20262443Keywords:
Malus domestica, Anticonvulsant activity, MES experimental model, Swiss Albino mice, MEMDP, Phenytoin sodiumAbstract
Background: Animal models for epilepsy have been used extensively to study the nature of seizures and epilepsy and to develop new therapies for epilepsy. In the present study, an effort has been made to evaluate the anticonvulsant activity of methanolic extract of Malus domestica peel (MEMDP) on epilepsy using maximal electroshock (MES) test in Swiss Albino mice.
Methods: The current study was prospective and single-center. Standard drugs: Phenytoin sodium 50 mg/kg orally (for MES test). Model used: MES. All drugs were administered orally to all 5 groups 45 minutes prior to experimentation with MES. Swiss Albino mice were weighed and marked, and then they were split into five groups of six at random (3 males and 3 females were included in each group).
Results: The MES test was performed on Swiss albino mice after grouping the animals. Six animals per group were used. Normal saline was used as a neutral control, and phenytoin sodium was used as positive controls. Doses of MEMDP used were 200 mg/kg, 400 mg/kg, and 800 mg/kg. MEMDP showed anticonvulsant activity with maximum activity at 400 mg/kg and 800 mg/kg body weight. The anticonvulsant activity of acute administration of 400 mg/kg and 800 mg/kg doses of MEMDP was comparable with phenytoin sodium at 50 mg/kg body weight (in the MES test).
Conclusions: The result of the present study indicates that MEMDP upon acute administration has significant anticonvulsant-like activity, which is comparable to phenytoin sodium.
References
Blume W, Luders H, Mizrahi E, Tassinari C, van Emde Boas W, Engel JJ. Glossary of descriptive terminology for ictal semiology: report of the ILAE task force on classification and terminology. Epilepsia. 2001;42(9):1212-8.
Rosa-Falero C, Torres-Rodríguez S, Jordán C, Licier R, Santiago Y, Toledo Z, et al. Citrus aurantium increases seizure latency to PTZ induced seizures in zebrafish thru NMDA and mGluR's I and II. Front Pharmacol. 2015;5:284
Sridharan R. Epidemiology of epilepsy. Curr Sci. 2002;82(6):664-70.
Reynolds E. Epilepsy in the world. Launch of the second Phase of the ILAE/IBE/WHO Global Campaign against Epilepsy. Epilepsia. 2001;43(6):46.
Birbeck G. Revising and refining the epilepsy classification system: Priorities from a developing world perspective. Epilepsia. 2012;53(2):18-21.
Hema B, Bhupendra S, Saleem TS, Gauthaman K. Anticonvulsant effect of Drosera burmanni Vahl Int J Appl Res Nat. 2009;2(3):1-4.
Fisher RS. Animal models of the epilepsies. Brain Res Brain Res Rev. 1989;14(3):245-78.
Löscher W, Schmidt D. New Horizons in the development of antiepileptic drugs: Innovative strategies. Epilepsy Res. 2006;69(3):183-272.
Smith M, Wilcox KS, White HS. Discovery of antiepileptic drugs. Neurotherapeutics. 2007;4(1):12-7.
Kandratavicius L, Balista PA, Lopes-Aguiar C, Ruggiero RN, Umeoka EH, Garcia-Cairasco N, et al. Animal models of epilepsy: use and limitations. Neuropsychiatr Dis Treat. 2014;10:1693-705.
Vogel HG, Hock FJ, Maas J, Mayer D. Drug discovery and evaluation, safety and pharmacokinetics assays. 3 edition. New York: Springer-Verlag. 2006.
Chandrashekar R, Adake P, Rao SN. Anticonvulsive activity of ethanolic extract of Acorus Calamus rhiozome in swiss albino mice. J Sci Inno Res. 2013;2(5):846-51.
Kumar KS, Kota K, Tahashildar J, Ragavendhra P. Antiepileptic activity of ethanolic extract of Biophytum sensitivum (L.) DC in Animal models. Int J Curr Res Aca Rev. 2015;3(7):23-30.
Wolfe K, Wu X, Liu RH. Antioxidant activity of apple peels. J Agri Food Chem. 2003;51(3):609-14.
Shabbir M, Khan MR, Saeed N. Assessment of phytochemicals, antioxidant, anti- lipid peroxidation and anti-hemolytic activity of extract and various fractions of Maytenus royleanus leaves. BMC Complement Altern Med. 2013;13:143.
Giomaro G, Karioti A, Bilia AR, Bucchini A, Giamperi L, Ricci D, et al. Polyphenols profile and antioxidant activity of skin and pulp of a rare apple from Marche region (Italy). Chem Cent J. 2014;8:45.
De Sarro G, Palma E, Costa N, Marra R, Gratteri S, De Sarro A, et al. Effects of compounds acting on GABA(B) receptors in the pentylenetetrazole kindling model of epilepsy in mice. Neuropharmacology. 2000;39(11):2147-61.
Nagakannan P, Shivasharan BD, Veerapur VP, Thippeswamy BS. Sedative and antiepileptic effects of Anthocephalus cadamba Roxb in mice and rats. Indian J Pharmacol. 2011;43(6):699-702.
Goldenberg MM. Overview of Drugs Used for Epilepsy and Seizures: Etiology, Diagnosis, and Treatment. Pharmacy Therap. 2010;35(7):392-415.
Inan SY, Buyukafsar K. Antiepileptic effects of two Rho kinase inhibitors, Y 27632 and fasudil, in mice. Br J Pharmacol. 2008;155(1):44-51.
Rodrigues MR, Kanazawa LK, das Neves TL, da Silva CF, Horst H, Pizzolatti MG, et al. Antinociceptive and anti-inflammatory potential of extract and isolated compounds from the leaves of Salvia officinalis in mice. J Ethnopharmacol. 2012;139(2):519-26.
Löscher W, Hönack D, Bloms-Funke P. The novel antiepileptic drug levetiracetam (ucb L059) induces alterations in GABA metabolism and turnover in discrete areas of rat brain and reduces neuronal activity in substantia nigra pars reticulata. Brain Res. 1996;735(2):208-16.
Gupta YK, Malhotra J, George B, Kulkarni SK. Methods and considerations for experimental evaluation of antiepileptic drugs. Indian J Physiol Pharmacol. 1999;43(1):25-43.